A protein, called DENND2B, commonly found in human cells can be an important switch that activates cancer cell metastasis, revealed researchers at the Montreal Neurological Institute and Hospital. This discovery significantly expands the understanding of epithelial cancers such as breast and lung cancer.
The researchers examined the function of a protein called DENND2B. During childhood development, DENND2B was found to play a role in the normal migration of cells. In adults cell migration is greatly reduced. However, in the case of cancer, there is unwanted cell migration, contributing to one of the most puzzling aspects of cancer cells, metastasis to new locations.
Breast Cancer - Prevention and Management with Lifestyle Changes
Lifestyle choices may or may not cause breast cancer but healthy lifestyle changes can open up avenues beyond breast cancer. Good habits will allow one to fight breast cancer and to live with dignity.
Advertisement
Principal researcher Peter McPherson said, "DENND2B activates another protein in the cell called Rab13, which is an enzyme that promotes cell migration."
Researcher Maria Ioannou said, "We found that Rab13 has an unusually high degree of expression in many forms of cancer, especially epithelial cancers that often metastasize to the brain. It was important to see exactly where in the cell Rab13 was being turned on to figure out how it functions. We saw that the DENND2B protein was activating Rab13 at the leading edge of the cell, an important point for cell migration."
![Cancer Pain]( "Cancer Pain")
Researchers see Rab13 as a focus for future research into cancer therapies. McPherson said, "In the case of the cells with reduced Rab13 levels, the cancer either did not grow at all or formed a smaller tumor and furthermore, the smaller tumor did not metastasize into other tissue. No one had considered targeting Rab13 in relation to cancer before this study. Clinical trials involving the discovery are still some time away."
The study will appear in the Journal of Cell Biology.
Source: Medindia
Advertisement
Researchers see Rab13 as a focus for future research into cancer therapies. McPherson said, "In the case of the cells with reduced Rab13 levels, the cancer either did not grow at all or formed a smaller tumor and furthermore, the smaller tumor did not metastasize into other tissue. No one had considered targeting Rab13 in relation to cancer before this study. Clinical trials involving the discovery are still some time away."
The study will appear in the Journal of Cell Biology.
Source: Medindia
Benefits of a Vegan Diet for Fighting Cancer
A vegan diet consisting of fruits, vegetables and other plant-based food sources has been shown to help prevent and fight many types of cancer.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.
New combination of medications trametinib and entinostat were found to decrease lung cancer in mice.
Combination treatment with TALZENNA and XTANDI was found to benefit prostate cancer patients, revealed study.
In leukemia patients, reduced amounts of dietary vitamin A is associated with a higher risk and severity of pancreatitis.